Literature DB >> 8093083

Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy muscle.

Y Mizuno1, S Noguchi, H Yamamoto, M Yoshida, A Suzuki, Y Hagiwara, Y K Hayashi, K Arahata, I Nonaka, S Hirai.   

Abstract

Dystrophin-associated glycoprotein complex is classified into two subcomplexes: the dystroglycan complex (156DAG and 43DAG) and the sarcoglycan complex (50DAG, A3b, and 35DAG). Severe childhood autosomal recessive muscular dystrophy (SCARMD) was first reported to result from a deficiency of 50DAG. We examined muscles from five SCARMD patients and found that dystrophin and 43DAG were present in almost normal levels while 35DAG and the newly-identified protein A3b in addition to 50DAG were absent or greatly reduced. Therefore, SCARMD is the disease with a selective defect of the sarcoglycan complex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8093083     DOI: 10.1006/bbrc.1994.2278

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  Creatine kinase, cell membrane and Duchenne muscular dystrophy.

Authors:  E Ozawa; Y Hagiwara; M Yoshida
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4.

Authors:  Kai Zhao; Chengyong Shen; Lei Li; Haitao Wu; Guanglin Xing; Zhaoqi Dong; Hongyang Jing; Wenbing Chen; Hongsheng Zhang; Zhibing Tan; Jinxiu Pan; Lei Xiong; Hongsheng Wang; Wanpeng Cui; Xiang-Dong Sun; Shihua Li; Xinping Huang; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2018-08-31       Impact factor: 6.167

3.  Sarcoglycan complex is selectively lost in dystrophic hamster muscle.

Authors:  Y Mizuno; S Noguchi; H Yamamoto; M Yoshida; I Nonaka; S Hirai; E Ozawa
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

4.  Reengineering a transmembrane protein to treat muscular dystrophy using exon skipping.

Authors:  Quan Q Gao; Eugene Wyatt; Jeff A Goldstein; Peter LoPresti; Lisa M Castillo; Alec Gazda; Natalie Petrossian; Judy U Earley; Michele Hadhazy; David Y Barefield; Alexis R Demonbreun; Carsten Bönnemann; Matthew Wolf; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2015-10-12       Impact factor: 14.808

5.  Lectin-binding characterizes the healthy human skeletal muscle glycophenotype and identifies disease-specific changes in dystrophic muscle.

Authors:  Brian J McMorran; M Carrie Miceli; Linda G Baum
Journal:  Glycobiology       Date:  2017-12-01       Impact factor: 4.313

Review 6.  Our trails and trials in the subsarcolemmal cytoskeleton network and muscular dystrophy researches in the dystrophin era.

Authors:  Eijiro Ozawa
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

7.  Mammalian alpha 1- and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus.

Authors:  A Suzuki; M Yoshida; E Ozawa
Journal:  J Cell Biol       Date:  1995-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.